Just read this today and see many others have already read it....

Just read this today and see many others have already read it.
It just makes me sick to read this and how Cook and the others have destroyed share holders wealth and Biota as a Company.
Read the article again and it will make you want to vomit...
DS had US$185.9 in sales for Inavir in Japan!!!
And why could this not have been rolled out into the rest of the world ????
Biota and its management was at the end all about mismanagement and greed and the dimise of a great Australian Company send overseas to be destroyed, cut off from the Share holders without duel listing.

Vaxart ( VXRT ) soared to a nearly 20% gain soon after Friday's opening bell following the drug discovery firm saying sales for its Inavir single-dose influenza vaccine generated more than JPY20 billion, or about $185.9 million, in sales for Japanese drug-maker Daiichi Sankyo Co. during the first three months of 2018, triggering a $5 million milestone payment for Vaxart. The upcoming payment, expected during Vaxart's current Q2 ending June 30, under a 2009 commercialization agreement between Daiichi and Biota Pharmaceuticals, which Vaxart - then known as Nabi Biopharmaceuticals (NABI) - acquired through a merger agreement completed in November 2012.